<div><div></div><div>Bio-Techne approved cash retention bonuses for named executive officers in connection with the contemplated merger.<div><table><tbody><tr><td>Individual</td><td>Kim Kelderman</td><td>Jim Hippel</td><td>William Geist</td><td>Shane Bohnen</td><td>Steve Crouse</td></tr><tr><td>Role</td><td>Named executive officer</td><td>Named executive officer</td><td>Named executive officer</td><td>Named executive officer</td><td>Named executive officer</td></tr><tr><td>Type of Change</td><td>Retention bonus approved</td><td>Retention bonus approved</td><td>Retention bonus approved</td><td>Retention bonus approved</td><td>Retention bonus approved</td></tr><tr><td>Effective Date</td><td>June 23, 2026 (effective upon execution of Merger Agreement)</td><td>June 23, 2026 (effective upon execution of Merger Agreement)</td><td>June 23, 2026 (effective upon execution of Merger Agreement)</td><td>June 23, 2026 (effective upon execution of Merger Agreement)</td><td>June 23, 2026 (effective upon execution of Merger Agreement)</td></tr><tr><td>Reason</td><td>To encourage retention and continued performance until the Effective Time</td><td>To encourage retention and continued performance until the Effective Time</td><td>To encourage retention and continued performance until the Effective Time</td><td>To encourage retention and continued performance until the Effective Time</td><td>To encourage retention and continued performance until the Effective Time</td></tr><tr><td>Replacement Info</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td></tr><tr><td>Background Details</td><td>Retention agreement provides $2,120,976 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td><td>Retention agreement provides $1,541,510 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td><td>Retention agreement provides $1,161,014 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td><td>Retention agreement provides $971,097 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td><td>Retention agreement provides $910,263 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td></tr><tr><td>Board/Committee Role Changes</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td><td>Not disclosed</td></tr></tbody></table></div>Original SEC Filing: BIO-TECHNE Corp [ TECH ] - 8-K - Jun. 25, 2026<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

TECH

Bio-Techne approved cash retention bonuses for five named executive officers, including Kim Kelderman and Jim Hippel, in connection with a contemplated merger. The bonuses, ranging from approximately $910,000 to $2.1 million, are designed to encourage retention until the merger's effective date of June 23, 2026. Payments are contingent upon continued employment or qualifying termination and the execution of a release.

Bio-Techne retention bonuses approved for Kim Kelderman, Jim Hippel